Socially active 60-year-olds face lower dementia risk

by University College LondonCredit: CC0 Public DomainBeing more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study.Thelongi

Updated on: June 14,2024

Socially active 60-year-olds face lower dementia risk

by University College LondonCredit: CC0 Public DomainBeing more socially active in your 50s and 60s predicts a lower risk of developing dementia later on, finds a new UCL-led study.Thelongi

Updated on:June 14,2024

New insights into the molecular mechanisms behind the action of secretagogin

byKarolinska InstitutetThe vesicular release of neurotransmitters and hormones relies on the SNARE-complex formed by three proteins: VAMP (blue), Syntaxin (pink) and SNAP-25 (green). Secretagoin

Updated on: April 28,2024

New insights into the molecular mechanisms behind the action of secretagogin

byKarolinska InstitutetThe vesicular release of neurotransmitters and hormones relies on the SNARE-complex formed by three proteins: VAMP (blue), Syntaxin (pink) and SNAP-25 (green). Secretagoin

Updated on:April 28,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on: April 16,2024

Alzheimer's drug gets FDA panel's backing, setting the stage for broader use

by Matthew PerroneThis Dec. 21, 2022, image provided by Eisai in January 2023 shows vials and packaging for their medication Leqembi. On Friday, June 9, 2023, health advisers backed the full approval

Updated on:April 16,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on: May 08,2024

Dementia and self-harm: Why it's crucial to support patients in first year after diagnosis

by Lachlan Gilbert,University of New South WalesCredit: AI-generated imagePeople diagnosed with dementia are more likely to self-harm within the first six to 12 months after initial diagnosis, h

Updated on:May 08,2024

Brain mapping technique reveals insights into brain's higher functions

byUniversity of BirminghamHigher-order brain mapping: schematic of the approach and applications. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54472-yA new way of mapp

Updated on: December 17,2024

Brain mapping technique reveals insights into brain's higher functions

byUniversity of BirminghamHigher-order brain mapping: schematic of the approach and applications. Credit:Nature Communications(2024). DOI: 10.1038/s41467-024-54472-yA new way of mapp

Updated on:December 17,2024

5α-reductase inhibitors linked to depression, but not dementia

by Elana Gotkine HealthDay Reporter5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published onl

Updated on: March 13,2024

5α-reductase inhibitors linked to depression, but not dementia

by Elana Gotkine HealthDay Reporter5α-reductase inhibitors (5-ARIs) are associated with an increased risk for depression but seem not to be associated with dementia, according to a study published onl

Updated on:March 13,2024

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on: February 27,2024

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on:February 27,2024

How molecules in the zebrafish brain indicate it's time to quit a fight

byRIKENCredit:Current Biology(2023). DOI: 10.1016/j.cub.2023.03.087Two RIKEN neuroscientists have uncovered a molecular switch in the zebrafish brain that causes a fish to quit fight

Updated on: January 12,2024

How molecules in the zebrafish brain indicate it's time to quit a fight

byRIKENCredit:Current Biology(2023). DOI: 10.1016/j.cub.2023.03.087Two RIKEN neuroscientists have uncovered a molecular switch in the zebrafish brain that causes a fish to quit fight

Updated on:January 12,2024

Focused ultrasound shown to enhance the delivery of promising therapeutic for Alzheimer's disease

by Samantha Sexton, Sunnybrook Research InstituteNew neurons (seen here in green) can be generated in the hippocampus, a brain region involved in learning and memory. In the study, the use of focused

Updated on: July 04,2024

Focused ultrasound shown to enhance the delivery of promising therapeutic for Alzheimer's disease

by Samantha Sexton, Sunnybrook Research InstituteNew neurons (seen here in green) can be generated in the hippocampus, a brain region involved in learning and memory. In the study, the use of focused

Updated on:July 04,2024

How the brain's immune system worsens epilepsy

by Richard C. Lewis,University of IowaUniversity of Iowa biologists have definitively linked the brain's immune system to epilepsy. The caption shows the sequence of events that triggers wor

Updated on: February 21,2024

How the brain's immune system worsens epilepsy

by Richard C. Lewis,University of IowaUniversity of Iowa biologists have definitively linked the brain's immune system to epilepsy. The caption shows the sequence of events that triggers wor

Updated on:February 21,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on: April 29,2024

Insurers balk at paying for Biogen's $56,000-a-year Alzheimer's treatment

by John Tozzi, Angelica Lavito and Anushree DaveCredit: CC0 Public DomainU.S. health insurers say they want more proof before paying for Biogen Inc.'s Aduhelm, stalling sales of the costly new Alz

Updated on:April 29,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on: May 06,2024

Dementia risk scores have high error rates

by Lori SolomonCurrent dementia risk scores have high error rates and limited clinical utility for estimating 10-year risk, according to a study published online June 13 inJAMA Network Open.Mika

Updated on:May 06,2024